Oxbryta (voxelotor) can help ease, or fully heal, painful leg ulcers in people with sickle cell disease (SCD), according to a post-hoc analysis of a Phase 3 trial. These promising findings support the launch of future trials investigating the potential benefits of Oxbryta — already conditionally approved in the U.S. — at treating leg ulcers in these patients, researchers say. Data from the post-hoc analysis was reported in “The Impact of Voxelotor Treatment on Leg…

You must be logged in to read/download the full post.